The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Dabigatran Versus Warfarin: Effects on Ischemic and Hemorrhagic Strokes and Bleeding in Asians and Non-Asians With Atrial Fibrillation
Open accessAbstract
Background and Purpose—: Intracranial hemorrhage rates are higher in Asians than non-Asians, especially in patients receiving warfarin. This randomized evaluation of long-term anticoagulation therapy subgroup analysis assessed dabigatran etexilate (DE) and warfarin effects on stroke and bleeding rates in patients from Asian and non-Asian countries. Methods—: There were 2782 patients (15%) from 10 Asian countries and 15 331 patients from 34 non-Asian countries. A Cox regression model, with terms for treatment, region, and their interaction was used. Results—: Rates of stroke or systemic embolism in Asians were 3.06% per year on warfarin, 2.50% per year on DE 110 mg BID (DE 110), and 1.39% per year on DE 150 mg BID (DE 150); in non-Asians, the rates were 1.48%, 1.37%, and 1.06% per year with no significant treatment-by-region interactions. Hemorrhagic stroke on warfarin occurred more often in Asians than non-Asians (hazard ratio [HR], 2.4; 95% confidence interval [CI], 1.3–4.7; P =0.007), with significant reductions for DE compared with warfarin in both Asian (DE 110 versus warfarin HR, 0.15; 95% CI, 0.03–0.66 and DE 150 versus warfarin HR, 0.22; 95% CI, 0.06–0.77) and non-Asian (DE 110 versus warfarin HR, 0.37; 95% CI, 0.19–0.72 and DE 150 versus warfarin HR, 0.28; 95% CI, 0.13–0.58) patients. Major bleeding rates in Asians were significantly lower on DE (both doses) than warfarin (warfarin 3.82% per year, DE 110 2.22% per year, and DE 150 2.17% per year). Conclusions—: Hemorrhagic stroke rates were higher on warfarin in Asians versus non-Asians, despite similar blood pressure, younger age, and lower international normalized ratio values. Hemorrhagic strokes were significantly reduced by DE in both Asians and non-Asians. DE benefits were consistent across Asian and non-Asian subgroups. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00262600.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
van Asch, C. J., Luitse, M. J., Rinkel, G. J., van der Tweel, I., Algra, A., & Klijn, C. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70340-0 · Cited by 2,658
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies
Strazzullo, P., D'Elia, L., Kandala, N.-B., & Cappuccio, F. P. (2009) · BMJ · doi:10.1136/bmj.b4567 · Cited by 1,580
Eikelboom, J. W., Wallentin, L., Connolly, S. J., Ezekowitz, M., Healey, J. S., Oldgren, J., Yang, S., Alings, M., Kaatz, S., Hohnloser, S. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004747 · Cited by 1,081 · cited 1×
“In contrast, we have previously reported that there is an interaction between age and the bleeding effects of both doses of dabigatran compared with warfarin, which indicates that the benefits of dabigatran compared with warfarin seen in younger patients are attenuated significantly in older patients.(6) This age inte…”
ResultMarini, C., De Santis, F., Sacco, S., Russo, T., Olivieri, L., Totaro, R., & Carolei, A. (2005) · Stroke · doi:10.1161/01.str.0000166053.83476.4a · Cited by 949
Shen, A. Y.-J., Yao, J. F., Brar, S. S., Jorgensen, M. B., & Chen, W. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.098 · Cited by 656
Diener, H.-C., Connolly, S. J., Ezekowitz, M. D., Wallentin, L., Reilly, P. A., Yang, S., Xavier, D., Di Pasquale, G., & Yusuf, S. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70274-x · Cited by 451
Self-citationCerebral microbleeds on MRI: Prevalence, associations, and potential clinical implications
Koennecke, H.-C. (2006) · Neurology · doi:10.1212/01.wnl.0000194266.55694.1e · Cited by 373
Ezekowitz, M. D., Connolly, S., Parekh, A., Reilly, P. A., Varrone, J., Wang, S., Oldgren, J., Themeles, E., Wallentin, L., & Yusuf, S. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.02.005 · Cited by 332
Self-citationLovelock, C. E., Cordonnier, C., Naka, H., Al-Shahi Salman, R., Sudlow, C. L. M., The Edinburgh Stroke Study Group, Sorimachi, T., Werring, D. J., Gregoire, S. M., Imaizumi, T., et al. (2010) · Stroke · doi:10.1161/strokeaha.109.572594 · Cited by 278
Warfarin Sensitivity Genotyping: A Review of the Literature and Summary of Patient Experience
Moyer, T. P., O’Kane, D. J., Baudhuin, L. M., Wiley, C. L., Fortini, A., Fisher, P. K., Dupras, D. M., Chaudhry, R., Thapa, P. B., Zinsmeister, A. R., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0278 · Cited by 139
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008): Digest Version
JCS Joint Working Group (2010) · Circulation Journal · doi:10.1253/circj.cj-88-0001 · Cited by 139
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008) : Digest Version
Ogawa, S., Aizawa, Y., Atarashi, H., Inoue, H., Kamakura, S., Koretsune, Y., Kumagai, K., Mitamura, H., Okumura, K., Sugi, K., et al. (2010) · Japanese Circulation Journal-english Edition · Cited by 130
Hori, M., Connolly, S. J., Ezekowitz, M. D., Reilly, P. A., Yusuf, S., Wallentin, L. C., & the RE-LY Investigators (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0191 · Cited by 113
Self-citationNieuwlaat, R., Connolly, B. J., Hubers, L. M., Cuddy, S. M., Eikelboom, J. W., Yusuf, S., & Connolly, S. J. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.08.024 · Cited by 43
Self-citationSeals, A. A., Haider, R., Leon, C., Francis, M. J., Young, J. B., Roberts, R., & Pratt, C. M. (1987) · Circulation · doi:10.1161/01.cir.75.4.800 · Cited by 18
Cited by
Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., et al. (2021) · EP Europace · doi:10.1093/europace/euab065 · Cited by 1,132
Global epidemiology of atrial fibrillation
Rahman, F., Kwan, G. F., & Benjamin, E. J. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.118 · Cited by 731
Stroke prevention in atrial fibrillation: An Asian perspective
Wang, K.-L., Lip, G. Y. H., & Chiang, C.-E. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-11-0948 · Cited by 287
Metadata
- Authors
- Hori, M., Connolly, S. J., Zhu, J., Liu, L. S., Lau, C.-P., Pais, P., Xavier, D., Kim, S. S., Omar, R., Dans, A. L., Tan, R. S., Chen, J.-H., Tanomsup, S., Watanabe, M., Koyanagi, M., Ezekowitz, M. D., Reilly, P. A., Wallentin, L., & Yusuf, S.
- Venue
- Stroke
- Published
- 2013-07
- Volume
- 44
- Issue
- 7
- Pages
- 1891-1896
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2116526419
- Cited by
- 327
- References
- 17
- FWCI
- 24.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.